Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
175 BRL | -2.02% | -.--% | +3.68% |
05-14 | Transcript : The Clorox Company Presents at Goldman Sachs Global Staples Forum, May-14-2024 08:15 AM | |
05-08 | Visa, PNC, Synchrony Among Companies Targeted in Cyberattack Campaign | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 72.34 times its estimated earnings per share for the ongoing year.
- The company appears highly valued given the size of its balance sheet.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Sector: Household Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.68% | 16.34B | - | ||
+13.17% | 26.17B | B+ | ||
-11.61% | 7.33B | A- | ||
+5.96% | 5.98B | C | ||
-6.01% | 3.05B | C+ | ||
-3.55% | 2.22B | A- | ||
-15.86% | 1.77B | C+ | ||
+39.33% | 1.05B | - | - | |
+2.74% | 663M | - | ||
-26.53% | 450M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CLX Stock
- CLXC34 Stock
- Ratings The Clorox Company